SATELEC - PIERRE ROLLAND – Trademark Portfolio

Entity Type: 03

SATELEC - PIERRE ROLLAND holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ACTEON. The owner is based in Merignac.

17 Avenue Gustave EiffelZI du Phare

Merignac 33700 , FR

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ACTEON
ACTEON
Registered 2003

Trademark Classifications

SATELEC - PIERRE ROLLAND's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does SATELEC - PIERRE ROLLAND have?

SATELEC - PIERRE ROLLAND has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SATELEC - PIERRE ROLLAND file in?

SATELEC - PIERRE ROLLAND files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SATELEC - PIERRE ROLLAND's most well-known trademarks?

SATELEC - PIERRE ROLLAND's registered trademark portfolio includes well-known marks such as ACTEON. These are among 1 currently registered trademark in the portfolio.

What is SATELEC - PIERRE ROLLAND's trademark registration success rate?

SATELEC - PIERRE ROLLAND has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.